查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1830974

血压监测设备市场

Blood Pressure Monitoring Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计血压监测设备市场将从 2024 年的 29.1 亿美元扩大到 2031 年的 59 亿美元，2025 年至 2031 年的复合年增长率预计为 10.6%。

市场洞察与分析师观点：血压监测设备对于识别患者的高血压至关重要。高血压是中风和慢性心臟病的重要风险因素，而中风和慢性心臟病是全球死亡的主要原因。近年来，家庭护理环境中血压监测设备的采用率显着增加。此外，人口老化、生活方式的改变和技术创新等因素也是血压监测设备市场成长的关键因素。这些设备能够及早发现患者的健康状况恶化。此外，先进的个人血压监测仪还可以实现远端健康追踪。

成长催化剂：心血管疾病发病率上升推动血压监测设备市场成长过去十年，血压监测设备的重大进步为患者和医疗保健提供者提供了管理各种疾病的创新方法，包括室性和房性心律不整以及室性心房颤动。心臟骤停、冠心病、先天性心臟缺陷、肺动脉高压、心臟衰竭和肺动脉压升高 (PA) 等心血管疾病 (CVD) 的盛行率不断上升，支持了增强监测技术的发展。易于使用和快速检测异常是血压监测设备的关键优势。根据世界卫生组织 (WHO) 的数据，每年约有 3000 万人中风。美国心臟协会预测，到 2035 年，美国将有超过 1.3 亿人患有某种形式的心血管疾病。

欧洲心臟学会报告称，心房颤动是最常见的心律不整疾病，占欧洲医疗支出的0.28%至2.6%。报告也指出，心房颤动患者的中风风险增加五倍，欧洲所有中风病例中有20%至30%与心房颤动有关。欧洲心臟学会 2016 年的一项研究发现，欧盟约有 760 万 65 岁及以上人士患有心房颤动，预计到 2060 年，这一数字将上升 89%，达到约 1,440 万。心房颤动的盛行率预计将从 2016 年的 7.8% 上升到 2060 年的 9.5%。根据 Biosense Webster 2019 年的一份题为「心房颤动对亚太地区的影响」的报告，亚太地区约有 1,600 万人患有心房颤动，预计到 2050 年，这一数字将上升到近 7,200 万。报告强调，中老年族群罹患此病的风险更高。

策略洞察报告细分和范围：「血压监测设备市场」根据产品、类型和最终用户进行分类。就产品而言，市场包括水银柱血压计、无液体血压计和电子血压计。就类型而言，市场分为臂式、腕式、指套式和其他类型。就最终用户而言，市场细分为医院和诊所、家庭护理机构、门诊手术中心和其他类型。

細項分析：就产品而言，血压监测设备市场分为水银柱血压计、无液体血压计和电子血压计。 2022 年，数位血压计市场占据了相当大的市场份额，预计在 2022 年至 2030 年期间将呈现最快的复合年增长率。数位血压计旨在精确测量血压和脉搏。它们通常比无液血压计更易于操作，将听诊器和仪表整合在一个单元中，并带有错误指示器。血压读数显示在小萤幕上，比传统的錶盘更容易读取。数位血压计对听障患者特别有益，因为他们不需要透过听诊器听心跳。

按类型划分，血压监测设备市场分为手臂式、腕式、手指式和其他类型。 2022 年，手臂式占据了最大的市场份额，预计在 2022 年至 2030 年期间将以最快的复合年增长率增长。基于手指的血压监测技术的工作原理与脉搏血氧仪类似，利用从使用者手指反射的光，透过光电容积图 (PPG) 评估血流，并由各种演算法进行解读。 2023 年 5 月，加州大学圣地牙哥分校的工程师推出了一款低成本夹子，它使用智慧型手机的相机和闪光灯在指尖测量血压。这款设备与客製化应用程式配合使用，目前的生产成本约为 80 美分，规模化后成本可能降至每台 10 美分。这项创新旨在简化常规血压监测，使其变得经济实惠且易于获取，尤其对于控制高血压的老年人和孕妇。

就最终用户而言，血压监测设备市场细分为医院和诊所、家庭护理机构、门诊手术中心等。 2022 年，医院和诊所占据了相当大的市场份额，而预计家庭护理机构在 2022 年至 2030 年期间的复合年增长率最快。医院和诊所是许多地区的主要医疗保健提供者。美国心臟协会报告称，中老年人心律不整的盛行率很高。心房颤动、缓慢性心律不整和传导系统疾病等疾病占心律不整病例的多数。例如，在美国，心律不整影响至少 230 万人，增加了中风和死亡的风险。此外，美国每年诊断出 90,000 例室上性心搏过速，占所有此类急诊就诊人数的 25%。 NCBI 报告显示，在 5,585 例因心律不整入院的患者中，有 2,020 例（36.1%）同时存在心律不整。因此，多专科医院数量的不断增长，以及人们对医院和诊所而非其他医疗机构的偏好，促进了该领域血压监测设备市场的扩张。

区域分析：从地理来看，全球血压监测设备市场分为亚太地区、欧洲、中东和非洲、北美以及南美和中美。 2022年，北美占据全球血压监测设备市场的最大份额，而亚太地区预计将在2022年至2030年期间实现最高的复合年增长率。

北美血压监测设备市场涵盖美国、加拿大和墨西哥。该地区市场的成长受到许多因素的推动，例如心臟病发病率的上升，以及旨在打造创新基于感测器的患者监测系统的持续研发。此外，许多血压监测设备领域的领先公司都位于该地区，这促进了市场的成长。

美国是北美乃至全球血压监测设备市场的最大贡献者。冠心病是美国居民死亡的主要原因之一。作为北美乃至全球最大的经济体，美国的人口趋势对该地区市场有着显着的影响，既有正面的一面，也有负面的一面。老龄人口的不断增长意味着该国对患者监测设备的需求将不断增加。

血压监测设备市场报告范围产业发展与未来机会：血压监测设备市场领导企业的主要倡议包括：

2023年1月，Valencell在数位健康领域推出了自有品牌产品线，其首款产品旨在透过一款直觉的应用程式搭配一款创新的非处方药（OTC）设备，帮助患者监测和管理高血压，该设备无需袖带或校准，即可透过手指精确测量血压。 2022年10月，欧姆龙医疗将其血压监测器产品组合升级为「互联」设备。此次重大升级旨在为使用者和医疗保健专业人员提供无缝、即时且精准的高血压管理。这些互联设备可透过OMRON Connect应用程式轻鬆传输资料。竞争格局与关键参与者：血压监测设备市场的知名公司包括欧姆龙医疗、伟伦公司、A&D医疗公司、顺泰医疗公司、美国诊断公司、Withings、通用电气医疗集团、迈科生命科技、GF健康产品公司、Spacelabs医疗保健和百特公司。这些公司专注于推进技术、改进现有产品并扩大地域范围以满足日益增长的全球消费者需求。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：血压监测设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：血压监测设备市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：血压监测设备市场－全球市场分析

  • 血压监测设备 - 全球市场概览
  • 血压监测设备－全球市场及2030年预测

第七章：血压监测设备市场-收入分析-依产品，2020-2030

  • 概述
  • 水银柱
  • 无液体血压计
  • 电子血压计

第 8 章：血压监测设备市场 - 收入分析 - 按类型，2020-2030 年

  • 概述
  • 手臂
  • 手腕
  • 手指
  • 其他的

第九章：血压监测设备市场-收入分析-按最终用户，2020-2030

  • 概述
  • 医院和诊所
  • 家庭护理设置
  • 门诊手术中心
  • 其他的

第 10 章：血压监测设备市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：血压监测设备市场 - 主要公司简介

  • Omron Healthcare
  • Welch Allyn, Inc.
  • A&D Medical Inc.
  • SunTech Medical, Inc.
  • American Diagnostics Corp
  • Withings
  • GE Healthcare
  • Microlife AG
  • GF Health Products, Inc.
  • Spacelabs Healthcare
  • Baxter

第 14 章：附录

简介目录
Product Code: TIPMD00002666

The blood pressure monitoring devices market is anticipated to expand from US$ 2.91 billion in 2024 to US$ 5.90 billion by 2031, with an estimated CAGR of 10.6% from 2025 to 2031.

Market Insights and Analyst Perspective:Blood pressure monitoring devices are essential for identifying hypertension in patients. High blood pressure is a significant risk factor for strokes and chronic heart diseases, which are leading causes of mortality globally. Recently, there has been a notable increase in the adoption of blood pressure monitoring devices in home care environments. Additionally, factors such as an aging population, lifestyle changes, and technological innovations are key contributors to the growth of the blood pressure monitoring devices market. These devices enable early detection of health deterioration in patients. Furthermore, advanced personal blood pressure monitors allow for remote health tracking.

Growth Catalysts:Rising Incidence of Cardiovascular Diseases Fuels Growth in Blood Pressure Monitoring Devices Market

Over the past decade, significant advancements in blood pressure monitoring devices have provided patients and healthcare providers with innovative ways to manage various conditions, including ventricular and atrial arrhythmias, as well as ventricular atrial fibrillation. The increasing prevalence of cardiovascular diseases (CVDs) such as sudden cardiac arrest, coronary heart disease, congenital heart defects, pulmonary hypertension, heart failure, and elevated pulmonary artery pressure (PA) supports the development of enhanced monitoring techniques. The ease of use and rapid detection of irregularities are critical advantages of blood pressure monitoring devices. According to the World Health Organization (WHO), approximately 30 million individuals experience strokes annually. The American Heart Association projects that over 130 million people in the US will have some form of CVD by 2035.

The European Society of Cardiology reports that atrial fibrillation is the most prevalent arrhythmia, accounting for 0.28% to 2.6% of healthcare expenditures in Europe. It also indicates that patients with atrial fibrillation face a fivefold increased risk of stroke, with 20% to 30% of all stroke cases in Europe attributed to this condition. A 2016 study by the European Society of Cardiology found that around 7.6 million individuals aged 65 and older in the EU had atrial fibrillation, with projections suggesting this number could rise by 89% to approximately 14.4 million by 2060. The prevalence of atrial fibrillation is expected to increase from 7.8% in 2016 to 9.5% by 2060. According to a 2019 report by Biosense Webster titled "The Impact of Atrial Fibrillation in Asia Pacific," around 16 million people in the Asia Pacific region suffer from atrial fibrillation, with estimates suggesting this could rise to nearly 72 million by 2050. The report highlights that middle-aged and elderly populations are at a higher risk of developing this condition.

Strategic Insights

Report Segmentation and Scope:The "Blood Pressure Monitoring Devices Market" is categorized based on product, type, and end users. In terms of product, the market includes mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. By type, the market is divided into arm, wrist, finger, and others. For end users, the market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others.

Segmental Analysis:In terms of product, the blood pressure monitoring devices market is divided into mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. In 2022, the digital blood pressure segment captured a significant market share and is projected to exhibit the fastest CAGR from 2022 to 2030. Digital blood pressure devices are designed for precision and accuracy in measuring blood pressure and pulse. They are generally easier to operate than aneroid monitors, featuring a stethoscope and gauge in one unit, along with an error indicator. The blood pressure readings are displayed on a small screen, making them easier to read than traditional dials. Digital monitors are particularly beneficial for hearing-impaired patients, as they do not require listening to heartbeats through a stethoscope.

By type, the blood pressure monitoring devices market is categorized into arm, wrist, finger, and others. In 2022, the arm segment held the largest market share and is expected to grow at the fastest CAGR from 2022 to 2030. Finger-based blood pressure monitoring technology operates similarly to pulse oximetry, utilizing light that reflects off the user's finger to assess blood flow through a photoplethysmogram (PPG) interpreted by various algorithms. In May 2023, engineers at the University of California San Diego introduced a low-cost clip that uses a smartphone's camera and flash to measure blood pressure at the fingertip. This device, which works with a custom app, currently costs about 80 cents to produce, with potential costs dropping to 10 cents per unit at scale. This innovation aims to simplify and make regular blood pressure monitoring affordable and accessible, particularly for older adults and pregnant women managing hypertension.

Regarding end users, the blood pressure monitoring devices market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held a substantial market share, while the home care settings segment is projected to experience the fastest CAGR from 2022 to 2030. Hospitals and clinics serve as the primary healthcare providers in many regions. The American Heart Association, Inc. reports that the prevalence of rhythm abnormalities among middle-aged and older adults is significant. Conditions such as atrial fibrillation, bradyarrhythmia, and conduction system diseases represent the majority of abnormal rhythm cases. For instance, cardiac arrhythmias affect at least 2.3 million individuals in the US, increasing the risk of stroke and mortality. Additionally, 90,000 cases of supraventricular tachycardia are diagnosed annually in the US, accounting for 25% of all emergency department visits for this condition. An NCBI report indicates that 2,020 (36.1%) out of 5,585 hospital admissions for cardiac arrhythmias involved concurrent arrhythmias. Thus, the growing number of multispecialty hospitals and the preference for hospitals and clinics over other healthcare facilities contribute to the expansion of the blood pressure monitoring devices market in this segment.

Regional Analysis:Geographically, the global blood pressure monitoring devices market is divided into Asia Pacific, Europe, Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest share of the global blood pressure monitoring devices market, while Asia Pacific is expected to achieve the highest CAGR from 2022 to 2030.

The North American blood pressure monitoring devices market comprises the US, Canada, and Mexico. The market's growth in this region is driven by factors such as the rising incidence of cardiac diseases and ongoing research and development aimed at creating innovative sensor-based patient monitoring systems. Furthermore, many leading companies in the blood pressure monitoring devices sector are based in this region, facilitating market growth.

The US is the largest contributor to the blood pressure monitoring devices market both in North America and globally. Coronary heart disease is a leading cause of death in the US. As the largest economy in North America and the world, demographic trends in the US significantly influence the regional market, both positively and negatively. The increasing elderly population suggests a higher demand for patient monitoring equipment in the country.

Blood Pressure Monitoring Devices Market Report Scope

Industry Developments and Future Opportunities:Key initiatives by leading players in the blood pressure monitoring devices market include:

In January 2023, Valencell launched its own branded product line in the Digital Health sector, with its first product aimed at helping patients monitor and manage hypertension through an intuitive app paired with an innovative OTC device that accurately measures blood pressure from the finger without the need for a cuff or calibration.

In October 2022, OMRON Healthcare enhanced its blood pressure monitor portfolio by converting them into "connected" devices. This significant upgrade was designed to provide users and healthcare professionals with seamless, real-time, and accurate hypertension management. The connected devices enable effortless data transfer through the OMRON Connect application.

Competitive Landscape and Key Players:Prominent companies in the blood pressure monitoring devices market include Omron Healthcare, Welch Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corp., Withings, GE Healthcare, Microlife AG, GF Health Products, Inc., Spacelabs Healthcare, and Baxter. These companies are focused on advancing technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Blood Pressure Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Blood Pressure Monitoring Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Blood Pressure Monitoring Devices Market - Global Market Analysis

  • 6.1 Blood Pressure Monitoring Devices - Global Market Overview
  • 6.2 Blood Pressure Monitoring Devices - Global Market and Forecast to 2030

7. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By Product, 2020-2030

  • 7.1 Overview
  • 7.2 Mercury Columns
  • 7.3 Aneroid Blood Pressure Monitors
  • 7.4 Digital Blood Pressure Monitors

8. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 8.1 Overview
  • 8.2 Arm
  • 8.3 Wrist
  • 8.4 Finger
  • 8.5 Others

9. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Homecare Settings
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Others

10. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Blood Pressure Monitoring Devices Market Overview
    • 10.1.2 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.5 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Blood Pressure Monitoring Devices Market
        • 10.1.6.1.1 United States Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.1.2 United States Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.1.3 United States Blood Pressure Monitoring Devices Market, by End User
      • 10.1.6.2 Canada Blood Pressure Monitoring Devices Market
        • 10.1.6.2.1 Canada Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.2.2 Canada Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.2.3 Canada Blood Pressure Monitoring Devices Market, by End User
      • 10.1.6.3 Mexico Blood Pressure Monitoring Devices Market
        • 10.1.6.3.1 Mexico Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.3.2 Mexico Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.3.3 Mexico Blood Pressure Monitoring Devices Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Blood Pressure Monitoring Devices Market - Key Company Profiles

  • 13.1 Omron Healthcare
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Welch Allyn, Inc.
  • 13.3 A&D Medical Inc.
  • 13.4 SunTech Medical, Inc.
  • 13.5 American Diagnostics Corp
  • 13.6 Withings
  • 13.7 GE Healthcare
  • 13.8 Microlife AG
  • 13.9 GF Health Products, Inc.
  • 13.10 Spacelabs Healthcare
  • 13.11 Baxter

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud